Literature DB >> 9525316

Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers.

L Qin1, D R Pahud, Y Ding, A U Bielinska, J F Kukowska-Latallo, J R Baker, J S Bromberg.   

Abstract

Starburst dendrimer, a structurally defined, spherical macromolecule composed of repeating polyamidoamino subunits, was investigated to augment plasmid-mediated gene transfer efficiency in a murine cardiac transplantation model. The grafts were directly injected with naked pCH110, a plasmid encoding beta-galactosidase (beta-Gal), or pCH110-dendrimer complex, and reporter gene expression determined by X-Gal staining. The grafts injected with pCH110-dendrimer demonstrated widespread and extended beta-Gal expression in both myocytes and the graft infiltrating cells from 7 to 28 days, compared to the grafts injected with naked pCH110 that expressed beta-Gal only in myocytes for less than 14 days. p alphaMHC-vIL-10, as plasmid encoding viral interleukin-10 (vIL-10) under the control of alpha-myosin heavy chain promoter, was able to prolong allograft survival from 13.9 +/- 0.9 days to 21.4 +/- 2.3 days (p < 0.005). When dendrimer G5EDA was used with p alphaMHC-vIL-10, 60-fold less DNA resulted in significant prolongation of graft survival to 38.6 +/- 4.7 days (p < 0.0005). The dose of DNA, the charge ratio of DNA to dendrimer, and the size generation of the dendrimers were all determined to be critical variables for prolongation of allograft survival in this model system. Thus, the use of the Starburst dendrimer dramatically increased the efficiency of plasmid-mediated gene transfer and expression. Production of immunosuppressive cytokines at higher amounts for longer periods of time in a greater expanse of tissue enhanced the immunosuppressive effect and prolonged graft survival further.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525316     DOI: 10.1089/hum.1998.9.4-553

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  7 in total

Review 1.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

2.  PAMAM dendrimers as delivery agents for antisense oligonucleotides.

Authors:  H Yoo; P Sazani; R L Juliano
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

Review 3.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

4.  Drug delivery to the posterior segment of the eye for pharmacologic therapy.

Authors:  Shalin S Shah; Lori Vidal Denham; Jasmine R Elison; Partha S Bhattacharjee; Christian Clement; Tashfin Huq; James M Hill
Journal:  Expert Rev Ophthalmol       Date:  2010-02-01

Review 5.  Cationic polymer based gene delivery systems.

Authors:  S C De Smedt; J Demeester; W E Hennink
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

6.  A single amino acid determines the immunostimulatory activity of interleukin 10.

Authors:  Y Ding; L Qin; S V Kotenko; S Pestka; J S Bromberg
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

7.  Liposome Lipid-Based Formulation Has the Least Influence on rAAV Transduction Compared to Other Transfection Agents.

Authors:  Pengpeng Guo; Chenghui Yu; Qingxin Wang; Ruirong Zhang; Xianze Meng; Yinglu Feng
Journal:  Mol Ther Methods Clin Dev       Date:  2018-04-12       Impact factor: 6.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.